News

Aldatu Secures 1 5 M NIH Grant to Commercialize HIV Drug Resistance Test

Subscribe to Gene Silencing/Gene Editing Horizon Discovery, Fulcrum Therapeutics Collaborate on Target Discovery Using CRISPR Screens

September 6, 2016 | By Maggie O’Toole

Share :

Previous Page Next Page